OxSonics Wins “Best Emerging UK Medtech Company” Award

Oxford, UK – 5 October 2015 – OxSonics Limited (“OxSonics”), University of Oxford spin-out company developing a new generation of ultrasound-based medical devices, today announced it had won the award for the “Best Emerging UK Medtech Company” at the OBN annual award ceremony. The awards celebrate the key achievements within the UK’s bioscience and medical […]

OxSonics Appoints Juniper Pharma Services as Contract Development & Manufacturing Organisation

Oxford, UK – 23 June 2015 – OxSonics Limited (“OxSonics”) has entered into a long-term contract development and manufacturing partnership with Juniper Pharma Services Ltd. (“Juniper”). Juniper will support OxSonics in the formulation development, scale-up and GMP manufacturing of OxSonics’ proprietary injectable “sono-sensitive particles”. OxSonics was established in July 2013 to develop and commercialise a […]

OxSonics Featured In MoneyWeek Magazine

London, UK – 2 April 2015 – OxSonics was featured in the latest issue of MoneyWeek Magazine, the UK’s best-selling financial magazine. To view the article please visit: http://moneyweek.com/penny-sleuth-oxford-university-spin-out-oxsonics/ PDF version

MHRA Case Study Illustrates How MHRA & OxSonics Help Cancer Drugs Go The Extra Mile

London, UK – 15 January 2015 – The Medicines and Healthcare products Regulatory Agency (“MHRA”) has helped OxSonics take a big step towards developing a revolutionary generation of ultrasound devices which aim to enhance delivery of anti-cancer drugs deep into solid tumours. OxSonics Limited (“OxSonics”) was established in July 2013 to develop and commercialise a […]